[Interview with Dr. Christoph Soppa, consultant physician, Munich. No additional budget burden]

MMW Fortschr Med. 2014 Nov 20;156(20):79.
[Article in German]
No abstract available

Publication types

  • Interview

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Budgets*
  • Cost-Benefit Analysis
  • Germany
  • Humans
  • International Normalized Ratio*
  • Long-Term Care / economics
  • National Health Programs / economics*
  • Self Care / economics*
  • Self Care / instrumentation*
  • Vitamin K / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Vitamin K